Gait Performance in Hypertensive Patients on Angiotensin-Converting Enzyme Inhibitors

George Claudene J.; Verghese Joe

首页> 外文期刊>Journal of the American Medical Directors Association >Gait Performance in Hypertensive Patients on Angiotensin-Converting Enzyme Inhibitors

【24h】

Gait Performance in Hypertensive Patients on Angiotensin-Converting Enzyme Inhibitors

机译：高血压患者使用血管紧张素转换酶抑制剂的步态表现

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

Objective: To examine the relationship between angiotensin-converting enzyme inhibitor (ACEI) use and gait performance in older adults.

机译：目的：探讨老年人血管紧张素转化酶抑制剂（ACEI）的使用与步态表现之间的关系。

著录项

来源
《Journal of the American Medical Directors Association》 |2016年第8期|共4页
作者
George Claudene J.; Verghese Joe;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类预防医学、卫生学;
关键词
Ace inhibitors; physical performance; gait;

机译：ACE抑制剂;身体表现;步态;

相似文献

外文文献
中文文献
专利

1. Gait Performance in Hypertensive Patients on Angiotensin-Converting Enzyme Inhibitors [J] . George Claudene J., Verghese Joe Journal of the American Medical Directors Association . 2016,第8期

机译：高血压患者使用血管紧张素转换酶抑制剂的步态表现
2. Elevated Homocysteine Concentrations Decrease the Antihypertensive Effect of Angiotensin-Converting Enzyme Inhibitors in Hypertensive Patients [J] . Qin Xianhui, Li Youbao, Sun Ningling, Arteriosclerosis, thrombosis, and vascular biology . 2017,第1期

机译：升高的同型半胱氨酸浓度降低了血管紧张素转化酶抑制剂在高血压患者中的抗高血压作用
3. In half of hypertensive diabetics, co-administration of a calcium channel blocker and an angiotensin-converting enzyme inhibitor achieved a target blood pressure of <130/80 mmHg: the azelnidipine and temocapril in hypertensive patients with type 2 di [J] . Katayama S, Kawamori R, Iwamoto Y, Hypertension research: Official journal of the Japanese Society of Hypertension . 2008,第8期

机译：在一半的高血压糖尿病患者中，同时使用钙通道阻滞剂和血管紧张素转化酶抑制剂可达到<130/80 mmHg的目标血压：氮卓平和替莫卡普利用于2型糖尿病的高血压患者
4. The Use of Angiotensin-Converting Enzyme Inhibitors for the Management of Heart Failure in Horses [C] . Conference of the American College of Veterinary Internal Medicine (ACVIM) . 2017

机译：使用血管紧张素转换酶抑制剂在马中的心力衰竭管理
5. Comparison of monotherapy with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in improving health outcomes among veteran patients with type 2 diabetes. [D] . Campbell, Heather M. 2011

机译：与血管紧张素转换酶抑制剂或血管紧张素受体阻滞剂单一疗法改善2型糖尿病退伍军人患者健康结局的比较。
6. A Single-Center Open-Label Randomized Parallel-Group Study Assessing the Differences Between an Angiotensin II Receptor Antagonist and an Angiotensin-Converting Enzyme Inhibitor in Hypertensive Patients with Congestive Heart Failure: The Research for Efficacy of Angiotensin II Receptor Antagonist in Hypertensive Patients with Congestive Heart Failure Study [O] . Nobuo Totsuka, Nobuhisa Awata, Katsuhito Takahashi, 2003

机译：评估充血性心力衰竭高血压患者血管紧张素II受体拮抗剂与血管紧张素转换酶抑制剂之间差异的单中心开放标签随机平行分组研究：高血压患者血管紧张素II受体拮抗剂的疗效研究充血性心力衰竭患者研究
7. Elevated Homocysteine Concentrations Decrease the Antihypertensive Effect of Angiotensin-Converting Enzyme Inhibitors in Hypertensive Patients [O] . Xianhui Qin, Youbao Li, Ningling Sun, 2017

机译：升高的同型半胱氨酸浓度降低了血管紧张素转化酶抑制剂在高血压患者中的抗高血压作用

Gait Performance in Hypertensive Patients on Angiotensin-Converting Enzyme Inhibitors

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅